Diagnosis and treatment of nonmetastasized superficial bladder cancer must be reconsidered

Lasermedizin

Volumn 15, Issue 4, 2000, Pages 206-211

  Hofstetter, A ^a   Zaak, D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

5 aminolevulinic acid; Laser; Photodynamic diagnosis and therapy; Superficial bladder carcinoma

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; BCG VACCINE;

ARTICLE; BLADDER CANCER; BLADDER WALL; CANCER DIAGNOSIS; CARCINOMA IN SITU; CYSTECTOMY; DYSPLASIA; LAMINA PROPRIA; LASER COAGULATION; PHOTODYNAMIC THERAPY; SUPERFICIAL CANCER; TUMOR CELL;

EID: 0033679839     PISSN: 0938765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0938-765x(00)80023-1     Document Type: Article

References (39)

1. Harnblasenkarzinom
2. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ
3. The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma
4. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer
5. Der Weft der transurethralen nachresektion beim oberflachlichen hamblasenkarzinom
6. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder
7. Prospective study for qualitiy controll of TUR of bladder tumors by routine 2(nd) TUR (ReTUR)
8. Diagnostic value of cytology of voided urine
9. Pathologists role in bladder cancer
10. The sensitivity of bladder wash flow cytometry, bladder wash cytology and voided cytology in the detection of bladder carcinoma
11. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer
12. Cancer detection by quantitative fluorescence image analysis
13. Clinical study in bladder tumors
14. The predictive value of flow cytometry and urinary cytology in the follow up of patients with transitional cell carcinoma of the bladder
15. Flow cytometric analysis of DNA content in bladder cancer: Prognostic value of the DNA index with respect to early tumor recurrence in G2 tumors
16. Flow cytometry for detection and evaluation of urinary bladder carcinoma
17. Langsschnittuntersuchungen von patienten mit einfachen hyperplasien und pTa-tumoren des urothels nach detektion mit 5-ALA
18. Frequent genetic alternations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
19. Ultraviolet cystoscopy in patients with bladder cancer
20. Photodynamic diagnosis in respiratory tract malignancy using an excimer dye laser system
21. Fluorescence spectra in lung with porphyrin injection
22. Photodynamic diagnosis (PDD) of early stage malignancies. Preliminary results in urology and pneumology
23. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescencE
24. Clinical evaluation for detecting superficial transition cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of protoporphyrin IX following topical application of 5-aminelevulinic acid: Preliminary resultS
25. Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid
26. Endoscopic detection of urinary bladder cancer with 5-aminolevulinic acid based fluorescence endoscopy
27. Die transurethrale elektroresektion von harnblasentumoren mit und ohne 5-aminolavulinsaure induzierter fluoreszenz-endoskopie (AFE)
28. Die 5-aminolavulinsaure induzierte fluoreszenz-endoskopie des oberflachlichen harnblasenkarzinoms
29. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis
30. Fluoreszenzquantifizierung bei der der 5-aminolavulinsaure induzierten fluoreszenzendoskopie des oberflachlichen harnblasenkarzinoms
31. Susceptibility of urothelium to neoplastic cellular implantation
32. The site of recurrence of non infiltrating bladder tumors
33. Muss die indikation zur zystektomie beim harnblasenkarzinom neu uberdacht werden?
34. Treatment of urological tumors by neodym:YAG laser
35. Applications of lasers in bladder cancer (1992)
36. Zerstorung von uretertumoren mit dem neodym:YAG laser
37. Der laser in der urologie